Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
acorda therapeutics
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
ampyra
antibiotics
apokyn
apomorphine
axial spondyloarthritis
bausch health
biogen
biotech
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
cluster headache
crispr
dalfampridine
deals
detroit blog main
detroit top stories
diagnostics
digital health
What
drug
2
×
new
2
×
acorda
approval
approved
bio
biogen’s
biopharmaceutical
companies
convo
cope
disease
earlier
episodes
failures
fda
friday
gets
help
late
littered
looms
meant
medications
nash
news
nod
parkinson’s
patients
price
remains
rival
road
roundup
stop
strategy
talk
treatment
working
Language
Current search:
abbvie
×
new
×
drug
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
